BioApplications Inc.

行业

替代蛋白, 设施农业与园艺, 渔业与水产养殖, 食品配料, 涂料, 种子与遗传育种, 兽医

主题

动物与水产疫苗, 畜禽生产与遗传育种, 植物基肉、乳、蛋, 精密发酵（蛋白质、乳制品、蛋类）

角色

研究机构 — “…orations with universities, research institutes, and industry partners (e.g., Amicogen, POSCO International, H…”

母公司 / 集团

Spin-off from Pohang University of Science and Technology (POSTECH)

为何属于生物经济

BioApplications Inc. 是生物技术公司，专注植物基生物制药制造平台和兽医疫苗开发。

发现途径

[Rubric] South Korea · animal-vaccines

尚未被列为已评级方案的供应商。

• 2025-06 最新状态: 该公司与Hanwha Plus第4号SPAC的合并计划于2025年被取消。 ↗ ↗ ↗
• 2026-09-07 바이오앱, 국군의학연구소와 업무협약...식물 플랫폼 활용 백신개발 < 제약·바이오 < 산업 < 기사본문 - 팜뉴스
  BioApps (바이오앱) is partnering with the Military Medical Research Institute to develop plant-platform-based “green vaccines” for both infectious and biologic agents, aiming to rapidly produce multistrain vaccines and support national vaccine security, with plans …
• 2026-07-28 바이오앱, 중기부 '2026 스케일업 팁스' 선정
  BioApps (바이오앱) has been selected as the principal entity for the 2026 Scale-Up TIPS project by the Ministry of SMEs and Startups. The company will lead a 3-year, 300 million KRW project to develop a noninvasive, topical hydrogel for canine and feline atopic …
• 2026-07-26 국립농업과학원-바이오앱, 그린바이오 미래 경쟁력 확보 위해 맞손
  BioApplications Inc. (바이오앱) is collaborating with the Korea National Institute of Agricultural Sciences to accelerate commercializing green bio tech. They will jointly research, share data and facilities, and leverage BioApps’ plant-based production platform …
• 2026-07-28 Development of Pet Atopic Dermatitis Treatment Begins in Earnest… BioApp Selected for Scale-up TIPS - 벤처스퀘어
  BioApp (BioApplications Inc.) is spearheading a government-supported R&D project under Korea’s Scale-Up TIPS to develop a plant-protein–based topical hydrogel for atopic dermatitis in dogs and cats, aiming for a two-track strategy of quasi-drug skin care …
• 2025-08-12 BioApp selected as a participating company for the "Green Vaccine-Based ASF Response Platform Development Project." - 벤처스퀘어
  BioApp (BioApplications Inc.) has been selected as a participating company in South Korea’s Green Vaccine Technology-Based Livestock Infectious Disease Rapid Response Platform Development Project to develop an ASF vaccine using plant-based technology, …
• 2025-05-18 바이오앱, 식물 백신 생태계 확대...에이엔폴리와 식물 유래 ECM 개발 MOU
  BioApplications Inc. (바이오앱) is collaborating with ENPOLY to develop and commercialize plant-derived extracellular matrix (ECM) for biotech, pharmaceuticals, and regenerative medicine, aiming to overcome limitations of animal-derived ECM and advance safer, …

股权与投资方 1

同类企业

Choong Ang Vaccine Laboratories Co., Ltd. · Green Cross Veterinary Products Co., Ltd. · GC Biopharma (GC녹십자) · Hualan Biological Engineering Inc. · INATA · Reber Genetics Co., Ltd. · China National Biotec Group Company Limited · Euglena Co., Ltd. - 株式会社ユーグレナ